参考文献/References:
[1]Ducat LG,Philipson LH,Andson BJ.Routine depression screening for patients with diabetes[J].JAMA,2014,312,(22):2413. [2]Sayah FA,Majumdar SR,Johnson JA.Association of Inadequate Health Literacy with Health outcomes in Patients with Type 2 Diabetes and Depression:Secondary Analysis of a controlled Trial[J].Can J Diabetes,2015,39(4):259-265. [3]Kahl KG,Schweiger U,Correll C,et al.Depression,anxiety disorders,and metabolic syndrome in a population at risk for type 2 diabetes mellitus[J].Brain Behav,2015,5(3):e00306. [4]Issa CM.Vitamin D and Type 2 Diabetes Mellitus[J].Adv Exp Med Biol,2017,996(1):193-205. [5]Han B,Wang X,Wang N,et al.Investigation of vitamin D status and its correlation with insulin resistance in a Chinese population[J].Public Health Nutr,2017,20(9):1602-1608. [6]Afzal S,Bojesen SE,Nordestgaard BG.Low 25-hydroxyvitamin D and risk of type 2 diabetes:A prospective cohort study and meta analysis[J].Clin Chem,2013,59(2):381-391. [7]Brouwer-Brolsma EM,Dhonukshe?Rutten R,Wijngaarden J,et al.Low vitamin D status is associated with more depressive symptoms in Dutch older adults[J].Eur J Nutr,2016,55(4):1525-1534. [8]金川云,胡建德.重型抑郁症患者血清维生素D水平的研究[J].中国健康心理学杂志,2017(11):1601-1604. [9]胡瑶,毛旭东,刘晓华,等.中重度抑郁症患者血清维生素D2/D3水平分析[J].上海交通大学学报(医学版),2017,37(3):359-362. [10]Westra S,Simsek S,Rutters F,et al.Low vitamin D levels are not a contributing factor to higher prevalence of depressive symptoms in people with Type 2 diabetes mellitus:the Hoorn study[J].Diabetic Medicine,2017,34(4):577-581. [11]Wang Y,Yang H,Meng P,et al.Association between low serum 25-hydroxyvitamin D and depression in a large sample of Chinese patients with type 2 diabetes mellitus[J].Journal of Affective Disorders,2017,224(10):56-60. [12]沈春瑾,郑艳安,朱颖,等.25(OH)D3水平与2型糖尿病抑郁症患者的相关性研究[J].中国煤炭工业医学杂志,2017,20(2):183-185. [13]李宝新,周雪,梁璇璇,等.老年男性2型糖尿病合并抑郁患者骨代谢指标与骨密度变化[J].中国医学前沿杂志(电子版),2015,7(12):17-20.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(19):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(19):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]柯 红.综合护理干预对促进抑郁症患者康复的临床效果分析[J].医学信息,2018,31(04):165.[doi:10.3969/j.issn.1006-1959.2018.04.062]
KE Hong.Clinical Effect of Comprehensive Nursing Intervention on Rehabilitation of Patients with Depression[J].Medical Information,2018,31(19):165.[doi:10.3969/j.issn.1006-1959.2018.04.062]
[4]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(19):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[5]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(19):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[6]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(19):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[7]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(19):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[8]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Medical Information,2022,35(19):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[9]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Medical Information,2022,35(19):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[10]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Medical Information,2022,35(19):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]